Stem cells are the body's ultimate shape-shifters, sustaining tissues by balancing two competing demands: maintaining their ...
Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that ...
The Journal of Thoracic Oncology states that 1.8 million people die each year from lung cancer, and 10-20% of them are ...
An individual could potentially use an AI model or a combination of models to engineer a dangerous pathogen, launch autonomous cyberattacks on power grids or hospital networks, or create and ...
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy ...
Pharmacogenomics offers growth via mainstream clinical integration, focusing on genetic-guided prescribing, diverse ...
Funding received in the initial years after an investigator first establishes their research lab can be pivotal in helping to ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results